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Purpose 
 The purpose of this paper is to provide a review of how North Carolina has responded to 
opioid exposed pregnancies. Opioid use is now referred to as a national epidemic (Hayes & 
Brown, 2012). Although North Carolina has not been immune to this public health epidemic, the 
Tar Heel state in many ways has been better positioned than other states to address the sharp rise 
of pregnant women dependent on opioids. This is due to North Carolina’s long history of 
leadership of substance use services and programs for women. The strength of these services is 
credited to years of consistent, focused, collaborative leadership from agencies across the state 
working together to best meet the needs of women and their children. Although, there are still 
tremendous needs to be addressed, this foundation of leadership has guided the state’s response 
to addressing the complex issues that encompass opioid exposed pregnancies.  
     Methods 
 The information presented in this report draws from a review of reported trends regarding 
opioid use and incidence of neonatal abstinence syndrome (NAS) in North Carolina and across 
the country. Further, evidence-based best practices of care for opioid exposed pregnancies are 
included.  Information was gathered and analyzed from three sources: a review of recommended 
initiatives for addressing the issue, a review of existing literature and summaries of state policies 
and actions to address the issue, and a qualitative study based on interviews with key informants 
in North Carolina.  
     Background 
 North Carolina has experienced a sharp rise in opioid use (Modarai, 2013). Women of 
childbearing age have increased use of both prescription opioids and heroin. When this 
population of women becomes pregnant, one result is an increase in newborns being diagnosed 
with neonatal abstinence syndrome (NAS) as a consequence of their opioid exposure in utero and 
subsequent withdrawal symptoms (Association of State and Territorial Health [ASTHO], 2014). 
Nationally, there has been a significant increase in the prevalence of NAS, from 1.20 per 1,000 
U.S. hospital births in 2000 to 3.39 per 1,000 U.S. hospital births in 2009. (Patrick et al., 2012).  
It is estimated that opioid exposed pregnancies in North Carolina has resulted in the 511% 
increase of NAS recently reported (North Carolina Center for Health Statistics, 2014). This rise 
in both opioid use and NAS has resulted in increased public health, medical, and political 
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attention to the issue (ASTHO, 2014). 
 There are multiple intervention opportunities across service systems and professionals 
engaging with this population, beginning before pregnancy and continuing throughout a child’s 
developmental milestones. The National Center on Substance Abuse and Child Welfare created a 
five‐point framework that addresses prevention and intervention opportunities across all stages 
of development for children affected by substance use (Young et al., 2009). This framework 
organizes the engagement opportunities that states can utilize to address substance use among 
women of childbearing age and their children (Young et al., 2009). The five-points include: 
Preconception, pregnancy, birth, postpartum or neonatal, and childhood and beyond. States vary 
regarding how they have approached the issue of substance use pertaining to women, pregnancy, 
and children at the varying intervention points. The following report will explore how North 
Carolina has approached the issue of substance use and specifically opioid use among women of 
childbearing age and their children.    
 Concluding the review of intervention efforts based upon the five-point framework, an 
exploratory qualitative study aimed at identifying the current challenges regarding opioids and 
pregnancy in North Carolina and how the state should move forward to best address this public 
health concern is reviewed. The study includes key-informant interviews with six leaders in the 
field of opioid exposed pregnancies from across the state to gather information. What emerged 
from the data is a need for a comprehensive change in practice among the wide range of 
professionals and agencies that serve women of child-bearing age that may experience an opioid 
exposed pregnancy. This change in practice would include increased knowledge, but also 
enhanced skills that are required to treat this population. The data revealed that women often 
experience gaps in care that lead to substandard or even harmful care, and that increased 
substance use screening efforts and increased medication assisted treatment providers are needed 
to address the issue. 
  North Carolina Pregnancy and Opioid Exposure Project 
 The North Carolina Pregnancy and Opioid Exposure Project (NCPOEP) was established 
in 2015 as a response to the need for accurate information and service information on this 
escalating public health issue.  NCPOEP serves as statewide source for information, resources 
and technical assistance regarding the subject of pregnancy and opioid exposure. The University 
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of North Carolina at Chapel Hill’s School of Social Work hosts NCPOEP. The project is funded 
by the federal Substance Abuse Prevention and Treatment Block Grant Fund as a project of the 
NC Division of Mental Health, Developmental Disabilities & Substance Abuse Services. 
NCPOEP is designed to inform a broader range of providers and settings that would interact with 
this population. The project is uniquely designed to provide information to three populations: (1) 
infant care providers working with families of an opioid-exposed newborn; (2) women of 
childbearing age and pregnant women who are taking opioids; (3) providers working with 
women of childbearing age or pregnant women who are taking opioids.  
Stakeholder Workgroup 
 The project began out of a grassroots response to the concerns voiced by communities 
and individuals’ desire to work together and coordinate efforts to respond to this growing 
statewide problem. In the fall of 2012, a multidisciplinary workgroup of stakeholders from 
across the state came together to discuss opioid use in pregnancy. The workgroup was comprised 
of disciplines that included obstetrics, neonatology, pediatrics, substance use disorders treatment, 
social work, care management, and pharmacy. Workgroup members built consensus around key 
messages related to opioid use in pregnancy.  
 In October 2013, a member of the workgroup presented at the North Carolina Perinatal 
Health Committee, which is a subcommittee of the Child Fatality Task Force, a legislative study 
commission that examines the causes of child death and makes recommendations to the 
Governor and General Assembly on how to reduce child death, prevent abuse and neglect, and 
support the safe and healthy development of children. The presentation discussed the formation 
of the NC Pregnancy and Opioid Exposure Stakeholder Work Group and covered key topics 
regarding opioids and pregnancy in North Carolina. (North Carolina General Assembly, 2013; 
Godwin, 2013).  The presentation included information about current intervention and 
prevention services available, evidence regarding the best approach for care, and facts about the 
harmful approach to remedy opioid exposed pregnancies through the threat of incarceration. 
Also shared was the needs around pregnancy and opioid exposure which included state-wide 
dissemination and adaption of fact-based information into practice, support of evidence based 
gender responsive substance use disorder treatment, and development of evidence based pain 
management protocols for pregnant women 
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Guidance Document and Website 
 Out of the workgroup came the development of the document, Pregnancy and Opioid 
Exposure: Guidance for North Carolina. This comprehensive document is designed to be 
utilized by a wide variety of professionals who serve women and their families and need 
information on the topic of pregnancy and opioid exposure. This document outlines the use of 
best practices by professionals in North Carolina.  
 In addition to the development of the guidance document, NCPOEP has developed a user 
friendly website, ncpoep.org that was launched in March of 2015. The NCPOEP website 
provides access to information tailored for women seeking information about their pregnancy, 
specific guidance information for professionals working with women and their children, and a 
wealth of information regarding resources.  
Survey to Assess Professionals  
 Women experiencing an opioid exposed pregnancy come in contact with many 
professionals who often have concerns and misinformation about the best practices in addressing 
the convergence of opioids and pregnancy (Center for Substance Abuse Treatment, 2009; 
National Collaborating Centre for Women‘s and Children’s Health [NCCWCH], 2010). Lack of 
knowledge, proper skills, and poor attitudes among these professionals can negatively impact 
health outcomes for the woman and child (Association of State and Territorial Health Officials 
[ASTHO], 2014; American College of Obstetricians and Gynecologists [ACOG], 2012; Center 
for Substance Abuse Treatment, 2009). To determine the level of knowledge, skills and attitudes 
of professionals commonly working with this population in North Carolina a statewide survey 
was conducted by members of the workgroup. This survey sought to gather information 
regarding the readiness of the workforce to accurately address the unique needs of women who 
may experience an opioid exposed pregnancy and the needs of their infants.  
 Voluntary study participants were asked to complete a 30-item anonymous electronic 
survey focused on knowledge, skills and attitudes regarding pregnancy and opioids. An 
electronic link to the survey was emailed to professionals who commonly provide services to 
women of childbearing age who may be taking opioids. These include medical, behavioral 
health, justice and child welfare professionals. Respondents included 909 participants 
representing 93 out of 100 counties in North Carolina completed the survey.  
 The study found that participants were generally optimistic about women with substance 
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use disorders being able to make a change in their circumstances, with assistance from recovery 
support systems. The results from the skills questions suggest that the majority of participants are 
talking with women about essential aspects of their lives, including behavioral health symptoms, 
family planning and traumatic events. When this is contrasted with the knowledge level of the 
majority of the professionals in this study, it is unclear if professionals are providing accurate 
information. The knowledge of the professionals on the subject matter in this study, overall, was 
uneven. The results suggest that there is an opportunity for increasing provider knowledge on 
these topics. Given the significant implications to maternal and infant health, there is urgency to 
provide professionals education so they may provide accurate information to this population.   
Conference 
 In March 2015, NCPOEP hosted the first statewide conference to address opioid exposed 
pregnancies. The conference titled, It Takes a Community-Pregnancy and Opioid Exposure: 
Improving Outcomes for Women, Infants, and Families, was held in Greensboro, NC. Individuals 
who work with women, infants, and families, who have experienced opioid exposure during 
pregnancy, were encouraged to attend the conference. Over 400 professionals from medical, 
behavioral health, child welfare, and justice divisions attended the conference. The various 
disciplines came together to learn and collaborate on how to maximize physical and emotional 
health outcomes. Existing knowledge and resources on the topic were shared. There was an 
emphasis on working in a manner that respects the individuals and families served. Included was 
a presentation by a nationally recognized expert in caring for women with opioid exposed 
pregnancies along with sixteen breakout sessions from a variety of expert perspectives. 
Task Groups 
 The conference was designed to encourage and enhance collaboration across professional 
disciplines within geographic regions across North Carolina. From these meetings sixteen task 
groups were created to cover the various geographic groups across the state. These sixteens 
groups discussed activities currently going on in their regions to address the issue of opioid 
exposed pregnancies, recognized challenges within the regions in addressing the issue, identified 
organizations and groups that are not represented within the task group, and established the next 
steps for the group. The intent of forming the task groups was for each group to continue to meet 
and address issues specific to their regions regarding opioids and pregnancy after the conference. 
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In the year since the conference, many task groups have continued to meet and many are 
forming. It has been found that groups that have a champion to help facilitate continuous 
collaboration have been most successful. There is currently a formal follow-up being conducted 
to determine which groups have continued to meet, what new groups have formed, and what 
were the goals and outcomes of the task groups thus far. The goal of the follow-up is to two-fold,  
to identify groups that have made progress in addressing the issue of opioid exposed pregnancy 
through task  groups and to provide any necessary technical support for regions where the task 
groups have not been as successful in meeting to address the needs of opioid exposed 
pregnancies in their region. 
  State-wide Seminars on Opioid Use Disorders and Treatment 
 In an effort to provide needed training and support to regions throughout the state, 
numerous one-day seminars focused on the challenge of opioid dependence with a focus on 
pregnant women, mothers, and their children were offered. Between 2012-2014, 470 health, 
behavioral health, child welfare, and criminal justice professionals participated in the one-day 
trainings. The seminars were offered to child welfare and foster care staff from departments of 
social services, family drug treatment court and family court teams, guardian ad litem staff, law 
enforcement and probation or parole officers, other health and domestic violence staff and 
volunteers, and substance abuse treatment staff. The trainings were provided through a Regional 
Partnership Grant from the US DHHS Administration for Children and Families, support from 
the North Carolina Division of MH/DD/SAS and the Governors Institute on Substance Abuse, 
Inc. The seminars focused on essential knowledge, skills, and attitudes to augment the 
effectiveness of those working with people with substance use disorders (SUD). Topics explored 
included medication-assisted treatment for SUD, pregnancy and drug use, alcohol and other 
drugs, medication management, HIV and hepatitis C, how infants are affected by in utero 
medication and drug exposure, how Neonatal Abstinence Syndrome is managed, and how to 
collaborate with treatment and medical providers.  
   Intervention Points and Recommendations  
 North Carolina’s opportunities to prevent the incidence of or to enhance the outcome of 
opioid exposed pregnancies can be measured along a continuum of care and services by applying 
this five-point framework. The framework asserts that there are five major intervention points to 
prevent prenatal substance exposure and ameliorate the impacts of substance-exposure in infancy 
8 
 
 
(Young et al., 2009). This framework will be applied to review services, policies, and programs 
that are in North Carolina to address this issue. In addition to the standard intervention 
opportunities regarding substance use, more specific recommendations regarding opioid use are 
provided. Further, particular examples of initiatives that North Carolina has implemented at each 
intervention point to address the issue will be highlighted. 
 
PRE-PREGNANCY This timeframe offers the opportunity to promote awareness of the effects 
of prenatal substance use among women of childbearing age and their family members. 
 
Intervention and prevention issues specific to opioids and pregnancy at the preconception point 
include family planning, information about opioid exposed pregnancies, screening, and measures 
to address opioid prescribing. 
Preconception Health and Family Planning Efforts  
 North Carolina has a rich history of leadership in preconception health. North Carolina’s 
preconception strategic plan outlines six priorities, which include pregnancy intendedness and 
substance use. These priorities support initiatives that would prevent or ameliorate opioid 
exposed pregnancies (North Carolina Department of Health and Human Services [NCDHHS], 
2008).  North Carolina has made efforts to increase consumer and community awareness about 
preconception health (NCDHHS, 2008). While most people believe that women should be 
healthy while they are pregnant often there is little done to consider preparing for pregnancy. 
These efforts shift the current focus on health during pregnancy to focusing on wellness before 
pregnancy. Strategies across the state are being put in place to increase awareness of the 
importance of pregnancy intendedness and integrating preconception health messages that 
include substance use and family planning with more health and wellness providers. North 
Carolina’s most recent perinatal health strategic plan for 2016-2020 was developed by over 125 
maternal and child health experts from across the state. The plan is based on a life-course 
approach. The plan includes initiatives that would help to prevent opioid exposed pregnancies 
through early substance use screening, increased availability of contraception for women, 
including long activing reversible methods, and more emphasis on care coordination that 
includes mental health screening, substance use, and reproductive life planning, and access to 
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health care.  
 North Carolina’s approach to preconception health include the recommendation of 
routine health promotion activities for all women of reproductive age should begin with 
screening women for their intentions to become or not become pregnant in the short and long 
term and their risk of conceiving either intended or not (NCDHHS, 2008). It is recommended 
that every woman of reproductive age should receive information and counseling about all forms 
of contraception (Moos et al., 2008). This strategy is beneficial for women using opioids because 
they are often being prescribed opioids for pain from a primary providers and chronic pain 
doctors, it is important for these providers to regularly engage in conversations about pregnancy. 
March of Dimes of North Carolina Preconception Health Campaign has an online site with 
resources for both providers and individuals that includes information about life planning (2015). 
The site also includes information about preconception health activities and projects in North 
Carolina (March of Dimes of North Carolina, 2015). The goal of reproductive life planning is to 
help clinicians engage with women who may become pregnant at each primary care visit with 
efficient, evidence-based strategies and resources to assist women to have healthier personal 
health outcomes, to decrease unintended pregnancies, and to decrease pregnancy complications. 
Further, women who are using opioids as prescribed or illegally should be counseled, when 
possible, regarding what are the recommendations for a woman who becomes pregnant and is 
using opioids.  
 Since it is important for women to be provided with information regarding the 
importance of early prenatal treatment coupled with MAT before they get pregnant (ASTHO, 
2014). Women should also be made aware about the possible outcome of NAS due to opioid 
exposure (ASTHO, 2014). It is recommended that all providers regularly discuss pregnancy 
intendedness with women of childbearing age (NCDHHS, 2008). Issues of preconception health 
are especially critical when considering women dependent on opioids that have begun MAT. 
This population of women who are in the early phases of MAT often become pregnant 
unintentionally because their endocrine functions have been normalized, thus allowing 
pregnancy to occur (Center for Substance Abuse Treatment, 2005). Currently a pilot study is 
being conducted in North Carolina to determine the training needs of MAT providers, 
specifically in public methadone programs, on family planning topics. This study aims to 
determine what, if any, information regarding family planning is provided to clients utilizing 
10 
 
public methadone programs. 
 North Carolina implemented the family planning waiver act, Be Smart, in 2005 to reduce 
unintended pregnancies by expanding eligibility for family planning services to men and women 
at or below 185% of the federal poverty level who do not otherwise qualify for Medicaid 
services (NCDHHS, 2014). This is a critical service for many women to obtain important 
reproductive health services, including annual physical exam, testing and treatment for STIs, 
elective sterilization, and contraception, including long acting reversible contraception. This 
Family Planning Waiver has provided services to thousands of women across the state. During 
the first year roughly 10,000 women received services and that number has continued to grow 
each year (NCDHHS, 2009). The program has drastically reduced Medicaid-covered costs 
associated with unintended pregnancies. According to the January 2009 Interim Annual Report 
for the program, 1,139 pregnancies were averted by pregnancy prevention during the second year 
of the waiver due to the existence of the program (NCDHHS, 2009). This resulted in a Medicaid 
cost savings of nearly $12,000,000 in just the first year (NCDHHS, 2009).    
Preconception Health and Screening for Substance Use 
 It is critical for women of childbearing age to be regularly screened for substance use, 
including opioid misuse, by various providers (ACOG, 2006; ACOG 2008). Regular and 
consistent use of Screening, Brief Intervention, and Referral to Treatment (SBIRT) by providers 
can help to provide early intervention, including connection to substance use disorder treatment. 
SBIRT is a an evidence-based, comprehensive, integrated public health approach to the delivery 
of early intervention and treatment services for persons with substance use disorders as well as 
those at risk for developing these disorders. Primary care centers, other medical providers, 
hospital emergency rooms, trauma centers and other community settings provide opportunity for 
early intervention with at-risk substance users before more severe consequences occur (Solberg 
et al., 2008). North Carolina is working to enhance substance use screening through SBIRTNC, 
including training to understand reimbursement (SBIRTNC, 2016). 
 In 2011, a five-year grant was awarded to the Division of Mental Health, Developmental 
Disabilities, and Substance Abuse Services of the North Carolina State Department of Health and 
Human Services (NC DHHS) by the Substance Abuse and Mental Health Services 
Administration (SAMHSA) (North Carolina Substance Abuse Professional Practice Board, 
2013) to develop SBIRTNC. SBIRT NC is a joint effort of the Governor's Institute (GI), the NC 
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Division of Mental Health, Development Disabilities, and Substance Abuse Services (DMH, 
DD, SAS), SAMHSA/CSAT, the NC Center of Excellence for Integrated Care, and Community 
Care of North Carolina (CCNC).  SBIRT is comprehensive, integrated health approach to the 
delivery of early intervention and treatment services for persons with substance use disorders and 
those who are at risk of developing these disorders. Part of this grant has been utilized to help 
train primary providers engaging with women of childbearing age to screen for substance use 
(SBIRTNC, 2016). The high rate of opioid use among women has placed special emphasis on 
screening for opioid use among this population at preconception and throughout pregnancy. In 
addition to training publicly funded obstetricians, the training is being extended to privately 
funded obstetrician practices as well. 
Opioid Prescriptions and Prevention Efforts 
  A number of important initiatives in North Carolina have been implemented to address 
the epidemic of prescription opioid abuse and overdose. These initiatives help prevent a woman 
of childbearing age from developing opioid dependence, thus reducing the occurrence of an 
opioid exposed pregnancy. The Chronic Pain Initiative (CPI) led by Community Care of North 
Carolina (CCNC) is a statewide comprehensive approach to addressing chronic pain and opioid 
misuse. The CPI grew from the Project Lazarus pilot program developed in Wilkes County, 
North Carolina (Albert, 2011). Project Lazarus uses a community-based approach and includes 
emergency department policies and practices, safer prescription training for primary care and 
chronic pain care managers (Community Care of North Carolina, 2016). 
  Another effort to curb the opioid epidemic is North Carolina’s implementation of a 
prescription opioid reporting system (North Carolina General Assembly, 2005). The reporting 
system is designed to assist with two initiatives to deter prescription opioid misuse. To help 
doctors to identify and refer patients to treatment who are misusing these substances and improve 
the state’s ability to identify people who abuse and misuse prescription drugs classified as 
controlled substances. In 2013, changes were made to the Controlled Substance Reporting 
System (CSRS) to address three key issues: One, to deter what are referred to as pill mills, a term 
to describe a doctor, clinic or pharmacy that is prescribing or dispensing powerful narcotics 
inappropriately or for non-medical reasons; two, to make it easier for doctors to review previous 
prescription-fill history to avoid duplicate prescriptions and to offer treatment as needed; and 
three, to provide more timely data, and to allow data tracking relating to atypical prescribing or 
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filling, as well as other provisions (North Carolina General Assembly, 2013). This reporting 
system is an important preventative measure, but has been found to have issues regarding its 
effectiveness. This is mainly due to the relatively low number of providers who are registered 
with and use the NC CSRS in their clinical practice. 
 A further initiative to prevent opioid misuse and overdose has been through the support 
of an innovations grant from the Centers for Medicare & Medicaid Services, the Mountain Area 
Health Education Center (MAHEC) developed a comprehensive chronic pain program that 
employs a nurse practitioner as the primary care manager for patients with chronic pain (Centers 
for Medicare & Medicaid Services, 2012). The goal is for patients to receive consistent care from 
their regular physician and avoid situations in which patients present to another provider with an 
urgent need for an opioid prescription. The nurse practitioner shares responsibility for the 
patient’s care with the patient’s primary care physician and ensures completion of all elements in 
the chronic pain program is conducted including a pain-specific history and physical 
examination, screening for a history of substance abuse or risk factors for potential abuse, 
obtaining informed consent and a signed controlled-substance agreement, developing a self-
management plan and goals for therapy, reviewing the NCCSRS database, and performing 
periodic urine drug screening. Further, MAHEC has expanded the role of behavioral health 
specialists to help patients strengthen their coping strategies. The goal is for patients to engage in 
the behavioral management of their pain.  
 A key contributor in policy leadership and advocacy efforts in the area of saving lives 
due to opioid use is the North Carolina Harm Reduction Coalition (NCHRC). NCHRC is North 
Carolina’s only comprehensive harm reduction program and engages in grassroots advocacy, 
resource development, coalition building and direct services for law enforcement and those made 
vulnerable by a variety risks including drug use and overdose. This grassroots advocacy 
organization has made tremendous strides in promoting the use and accessibility of naloxone. 
This is a critical issue within the state because North Carolina has been ranked 20th in the nation 
for opioid overdose death rates (Modarai, 2013).  The greatest concentration of both high rates of 
prescription opioid sales and overdoses have occurred in the southern and western corners of 
North Carolina (Modarai, 2013). 
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Intervention and prevention issues specific to opioids at the prenatal or pregnancy point include 
substance use screening, MAT, and accessing treatment. Prenatal Screening: 
 Screening for substance use is important throughout the life course of a woman, including 
when she is pregnant. This is a critical point to identify a substance use issue and to provide the 
necessary care (Moyer, 2013; USPSTF, 2009). A 2009 mixed methods assessment of perinatal 
substance use screening was conducted across the state of North Carolina that revealed a 
troubling lack of prenatal screening (Louison, 2009). The survey suggested that maternal health 
program substance abuse screening and intervention policies and practices varied widely across 
the state. Many maternal health substance abuse polices were unclear or lacked detail about 
procedures and protocols in health departments. The results found that only about half (49%) of 
maternal health programs were screening all prenatal care patients at intake. The survey found 
that only 5% of programs screened at regular intervals throughout pregnancy. Of the programs 
that were screening for substance use only 23% are using validated screening tools. Since this 
survey was conducted there have been significant changes in maternal health programs in North 
Carolina. Maternal health programs that were part of the study have since transitioned and the 
majority of women of North Carolina covered by Medicaid are now served through Community 
Carolina of North Carolina (CCNC) Pregnancy Medical Home (PMH) (Community Carolina of 
North Carolina, 2016). The CCNC PMH has a policy and a standardized screening tool that is 
used with over 90% of women seen for prenatal care in the CCNC PMH setting. 
 A 2013 North Carolina survey of 104 prenatal healthcare providers designed to assess 
preparedness to engage women experiencing opioid exposed pregnancies, found only 17% 
prenatal care professionals stated that they had received SBIRT training. Although this sample 
reported a high level of comfort discussing substance use with women of childbearing age, it is 
possible that the high skill and attitude level, which was self-assessed, does not indicate that 
professionals are actually effective in their engagement with women experiencing opioid 
exposed pregnancies. It has been found that health professionals who ranked themselves as 
2. PRENATAL-This intervention point encourages health care providers to screen pregnant 
women for substance use as part of routine prenatal care and make referrals that facilitate 
access to treatment and related services for women who need those services.  
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“adequately trained” and “effective” at screening for substance use among women and referring 
to treatment actually did a very poor job of screening and referring their pregnant clients to 
treatment (Tandon, Parillo, Jenkins, 2005). This suggests that high levels of self-assessed skills 
and positive attitudes do not translate to clients being adequately screened and referred to needed 
treatment services. These studies provide support that the state needed to enhance their screening 
efforts and is moving in the right direction by ramping up their screening efforts since 2011 and 
by using an effective model, the SBIRT (SBIRTNC, 2016).  CCNC PMH is helping to address 
this by working with SBIRTNC to provide training in the prenatal settings, including 
reimbursement information (Community Care of North Carolina, 2015). The scope of help goes 
beyond the target population of CCNC PMH, of publicly insured women, to include an important 
collaborative piece positioned to impact practices that include privately insured women. It will 
be important to continue to monitor and evaluate screening efforts and outcomes among pregnant 
women and among all women of childbearing age.    
Medication Assisted Treatment (MAT) 
 There are different experiences that lead to an opioid exposed pregnancy and different 
paths for care and treatment. For example, some women are in active addiction who may be 
using prescription opioids or heroin, some women who are in recovery are enrolled in a MAT 
program receiving prescribed methadone or buprenorphine, and some women who experience 
chronic pain are taking opioids as prescribed (Center for Substance Abuse Treatment, 2005). 
When a pregnant woman is dependent on opioids due to chronic pain treatment and becomes 
pregnant, but does not have an opioid use disorder, it is recommended that she should continue 
with her pain prescriber with her pain prescriber working closely with her obstetrician to provide 
optimal care. If the woman has an opioid use disorder the best outcomes for mother and infant 
are achieved when the mother is involved in a comprehensive MAT program (Jones, Finnegan & 
Kaltenbach, 2012).  
 Research has demonstrated significant access barriers to MAT programs for both 
methadone and buprenorphine (Jones et al., 2015). For methadone the barriers include waiting 
lists for treatment, limited geographic coverage, limited insurance coverage, and the requirement 
that many patients receive methadone at clinics daily (Gryczynski et al., 2011; Andrews, Shin, 
Marsh, & Cao, 2001; Rosenblum et al., 2011; Sigmon, 2014). Similar to methadone, barriers 
exist for patients seeking MAT with buprenorphine, including provider availability and 
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willingness to prescribe, limited insurance coverage, and cost (Greenfield, Owens, Ley, 2014; 
Volkow, Frieden, Hyde, Cha, 2014; Sohler et al., 2013; Roman PM, Abraham AJ, Knudsen HK, 
2011). 
 In North Carolina there are 34 certified physicians to prescribe MAT with buprenorphine 
to a limit of 34 patients while there are 22 certified physicians with who are permitted to 
prescribe to 100 patients (Substance Abuse and Mental Health Services Administration, 2015). 
However, not all providers who are DATA 2000 certified are not providing MAT services and 
many are not serving the maximum patient quota that is permitted (Jones et al., 2015). There are 
gaps between treatment need and capacity to meet those needs. This exists at the state and 
national levels. North Carolina, like the rest of the country, needs strategies to increase the 
number of MAT providers (Jones et al., 2015). This shortage of MAT providers is further 
complicated by a lack of access to care due to cost or distance to a provider based on geography 
(Jones et al., 2015). Pregnant women often face additional barriers in obtaining MAT, especially 
buprenorphine (Holbrook & Nguyen, 2015). This is because providers are often unwilling to 
prescribe to a woman when she becomes pregnant and many women who were receiving MAT 
from a provider will be discontinued care when the physician knows the woman is pregnant. 
Significant gaps between treatment need and capacity exist in North Carolina and many 
providers not treating the maximum clients that they are permitted contributes to this gap and 
strategies to increase the number of MAT providers are needed (Jones et al., 2015). 
Statewide Hotline  
 Through the Alcohol/Drug Council of North Carolina the statewide Perinatal Substance 
Use Project is in place that provides a telephone hot-line, screening, information, and appropriate 
referrals for women throughout North Carolina who are pregnant or parenting and using 
substances. This project is funded jointly by NC DMH, DD, SAS, and the NC Division of Public 
Health. The project coordinator has noted that the majority of the calls that they receive currently 
are from pregnant women dependent on opioids seeking assistance. The project provides 
information on bed availability for substance use services in the residential treatment programs 
of the NC Perinatal Maternal and CASAWORKS Initiative, on a weekly basis. The project also 
provides training and technical assistance to agencies and providers working with women who 
are pregnant or parenting on issues related to substance use. The target population of this project 
is pregnant, parenting women and women seeking to regain custody, who are using substances.   
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Treatment Services  
 Women in North Carolina who are pregnant and using substances can access treatment 
through the North Carolina Division of Mental Health, Developmental Disabilities, and 
Substance Abuse Services Perinatal and Maternal Substance Abuse Initiative. There are 28 
specialized programs for substance using pregnant and parenting women and their children that 
provide evidence-based, comprehensive, gender-specific substance use treatment including 
outpatient and residential services (Division of Mental Health, Developmental Disabilities, and 
Substance Abuse Services, North Carolina Department, 2005). Women seeking to regain custody 
of their children are also included in this target population; however, they are only eligible for 
the outpatient treatment. For many women, experiencing a pregnancy is when they find 
themselves motivated to enter treatment (Mitchell, 2008). Research supports that receiving 
gender-specific substance abuse treatment positively impacts women’s length of stay in 
treatment and the likelihood of maintaining recovery after treatment (Ashley, Marsden, &Brady, 
2003; Goler NC, Armstrong, Taillac, & Osejo, 2008) 
North Carolina Policy and Prenatal Substance Use 
 It is thought that the rise in opioid exposed pregnancies contributed to the proposed 2015 
North Carolina State Senate proposed bill, an act to create the criminal offense of prenatal 
narcotic drug, SB 297. The bill passed the first reading, but ultimately was not enacted. 
However, there is the possibility that it might be reintroduced in the next Legislative session. The 
bill would create a new crime of assault if a woman uses narcotic drugs during pregnancy and if 
this use results in her child being “born addicted” to or harmed by the narcotic drug taken while 
pregnant (North Carolina, 2015). Research shows that the threat of incarceration among pregnant 
substance using women results in worse birth outcomes (Association of Women's Health, 
Obstetric and Neonatal Nurses, 2015). This is due to women avoiding prenatal care, and missing 
opportunities to connect to substance use disorder treatment (Flavin & Paltrow, 2010). In the 
event that this bill would resurface it is important that advocates of maternal and child health are 
prepared to promote programs and policies that would produce greater maternal and infant 
outcomes during the prenatal period.  
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Intervention and prevention issues specific to opioids at the intervention point of birth include 
effective pain management during labor and delivery and screening and proper care for NAS. 
Labor and Delivery 
 Community Care of North Carolina outlines, in their document that provides guidance for 
working with patients taking opioids during pregnancy, that providers should work with the 
patient and the delivery facility to establish a plan for pain management during labor and 
delivery. It is important that those providing care during labor and delivery understand that in 
general, patients undergoing opioid maintenance treatment will require higher doses of opioids to 
achieve pain relief than other patients and Narcotic agonist–antagonist drugs should be avoided 
because they may precipitate acute withdrawal (ACOG, 2012; Meyer et al., 2007; Jones et al., 
2009). 
Infant Screening 
 There is not a mandate for universal toxicology screening or even a set protocol for how 
hospitals in North Carolina should decide when to test for substance exposure for newborns in 
hospital maternity settings. Since this is not a standard policy for screening, it is typically up to 
the discretion of the hospital staff that may suspect substance use. This lack of protocol has 
likely led to bias practices regarding who is tested for substance use in hospitals because based 
on historical evidence there is a disparity among poor and women of color for being screened 
(Roberts, 1991; Center for Reproductive Rights, 2000).  
 The federal Child Abuse Prevention and Treatment Act’s (CAPTA) provision of the 2003 
Keeping Children and Families Safe Act outlines that hospitals that suspect that a newborn infant 
was substance exposed in utero they should be screened in the hospital, if positive, then Child 
Protective Services (CPS) should be contacted (US Department of Health and Human Services 
[USDHHS], 2003). CAPTA requires states to create policies and procedures to address the needs 
of infants born and identified as being affected by illegal substance use or withdrawal symptoms 
resulting from prenatal substance exposure (USDHHS, 2003). This includes appropriate referrals 
to child protection service systems. CAPTA includes a requirement that health care providers 
3. BIRTH-Interventions during this timeframe incorporate testing newborns for substance 
exposure at the time of delivery. Use consistent and effective protocols for identification of 
substance- exposed newborns. Make referrals for developmental or child welfare services. 
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involved in the delivery or care of such infants notify the child protective services system of the 
occurrence of such condition of such infants (USDHHS, 2003). North Carolina’s policy and 
practice is consistent with this requirement, and includes prenatal alcohol exposure as cause to 
refer to child protective services (NCDHHS, 2005). Each County’s Department of Social 
Services (DSS) accepts referrals for infants reported to have been exposed to substances 
prenatally, at the time of birth. When a referral is made by the health care provider, DSS utilizes 
a structured intake tool (NCDHHS, 2005).  
 In North Carolina, substance use during pregnancy alone is not reportable to the 
Department of Social Services because this type of exposure is not in the state’s definitions of 
child abuse or neglect (Child Welfare Information Gateway, 2016). However, CAPTA does 
require hospital staff to refer newborns identified as exposed to illicit substances to the 
Department of Social Services (Child Welfare Information Gateway, 2016).  North Carolina’s 
DSS policy for infants with positive toxicology at birth indicates that a mother's positive 
screening along with the infant's negative screening does not warrant a CPS assessment 
(NCDHHS, 2005). If a mother’s screen is positive while the infant's is negative and there is past 
account that specifies that a child may be at risk, a CPS assessment is merited. Also warranting a 
CPS report is when newborns who have a positive urine or meconium toxicology for drugs or 
alcohol. From this point the assessment would determine what the next steps would be, including 
removal of the infant. 
Perinatal Quality Collaborative  
 Perinatal Quality Collaborative of North Carolina (PQCNC) is a statewide initiative with 
the mission to “make North Carolina the best place to give birth and be born” (2015). PQCNC 
has a number of initiatives, including NAS. PQCNC recognizes that while NAS is a growing 
problem in North Carolina hospitals there remains no standard of care or treatment. Additionally, 
there is wide variation in the care treatment offered such infants across and within hospitals 
across the state. Through a statewide collaboration, PQCNC has developed standards of care 
within in NC hospitals for the NAS. In 2013 NAS experts from across the state began the process 
of developing PQCNC’s new NAS initiative. What has since emerged are very specific measures 
that are being used to indicate adherence and outcomes. Included in this measure is the “bundles 
of care” which require full adherence to the standards of care by hospital providers of both 
pharmacological and non-pharmacological care in order for a patient’s care to be counted as 
19 
 
compliant. Pharmacological care, includes primary medication is recommended, escalations < 1 
during stay, rescues < 1 during stay, and verbal communication of plan of treatment and follow 
up to outpatient doctor. Non-pharmacological care, includes breastfeeding or lactation consult if 
not breastfeeding, parents skin to skin once during stay (or more), parents participate in scoring 
once during stay (or more), and if infant not held by parent or family member then held by 
volunteer. The expert team working to coordinate this initiative has now completed the first stage 
of the project and is currently implementing the second phase of the initiative.  
 
Intervention and prevention issues specific to opioids at the intervention point of 
neonatal/postpartum include continued treatment and recovery support, pediatric support, and 
child development and parenting support. 
 Recovery and Treatment 
 It is essential for hospitalized pregnant women who initiated opioid-assisted therapy to 
make a next-day appointment with a treatment program before discharge (ACOG, 2012). It is 
important for women to be connected with treatment services as needed. If women are in 
recovery it is important for women to get the support required to cope with the stress of a 
newborn. 
Pediatric Support 
 Infants born exposed to opioids in utero should be closely monitored for NAS and other 
effects of opioid use by a pediatric health care provider (Kocherlakota, 2014). Close 
communication between the obstetrician and pediatrician is necessary for optimal management 
of the infants experiencing NAS (ACOG, 2012).  
Child Development and Parenting Supports 
 Often, infants who were exposed to substances or who were treated for NAS are also 
premature or were of low-birth weight. These infants and their families are routinely referred to 
early intervention services across the state. These programs include Care Coordination for 
4. NEONATAL/POSTPARTUM- Provide developmental services. Ensure an environment safe 
from abuse and neglect. Respond to immediate needs of other family members, including 
treatment of the parent-child relationship.  
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Children (CC4C), Children's Developmental Services Agencies (CDSAs), and four evidence-
based home visiting programs. These programs help to enhance health outcomes of the infants 
while women and families with young children offers information, guidance, risk assessment, 
and parenting support at home.  
 
Intervention and prevention issues specific to opioids at the last intervention point of childhood 
and adolescents, include continued family support. 
 Data on long-term outcomes of infants experiencing utero opioid exposure are limited, 
however, earlier studies have not found significant differences in cognitive development between 
children up to five years of age exposed to methadone in utero and control groups (Kaltenbach  
& Finnegan, 1984). Preventive interventions are recommended at this intervention point that 
focus on early childhood development (Hans, 1989). Research findings suggest that maternal 
substance use is not the most important factor in how opioid exposed infants and children 
develop it is more, however, factors that pertain to family characteristics and functioning of the 
family that play a significant role (Kocherlakota, 2014). This supports the need for North 
Carolina to continue to address the needs of the entire family and provide support where it is 
required throughout the life course. 
    Limitations and Strengths 
 A weakness of this study is the author’s limited knowledge of the issue, which could have 
resulted in an incomplete review of the scope of interventions conducted across the state to 
address the issue. However, the author did receive guidance for the study from two leaders in the 
field of perinatal substance use in North Carolina, who served as faculty advisors for this study. 
Strengths of the study include the application of the five-point intervention framework to review 
efforts to address opioid exposed pregnancies. This approach allowed for a systematic review of 
5. THROUGHOUT CHILDHOOD AND ADOLESCENCE- Identify and respond to needs of 
exposed child. Respond to needs of mother and other family members. Provide an appropriate 
education, screening, and support as exposed children approach adolescence and adulthood to 
prevent adoption of high-risk behaviors such as substance abuse. 
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intervention-points where the state is having success addressing the issue and identifying areas 
that need further attention.  
   Current Challenges and Recommendations 
 A qualitative study was conducted by the author to further explore the current challenges 
facing North Carolina in addressing opioid exposed pregnancies and how to best address those 
challenges. Interviews were conducted with leaders in the field of opioid exposed pregnancies in 
North Carolina. The research question was: What are the current challenges facing North 
Carolina in addressing opioid exposed pregnancies and how should these challenges be 
addressed? This pilot study provided important insights from those working in the field from 
across the state as to what needs to be done to best address this issue.  
 Purposeful sampling and snowball sampling was applied for this research. The sample 
was selected based on the individual’s experience and knowledge of the issue of opioid exposed 
pregnancies and experience in addressing this issue in North Carolina. Effort was also made to 
recruit individuals from various regions in the state. The two faculty advisors for this project 
assisted with the recruitment of participants. Six individuals who were identified as leaders or 
experts who work in the field of opioid exposed pregnancies across the state of North Carolina 
participated in the research study. The sample included a prenatal nurse, a neonatologist, a 
substance use counselor, a behavioral health clinical director, a prenatal behavior health 
counselor, and a perinatal substance use project coordinator. Although, all participants are 
leaders in the field of opioid exposed pregnancies they represent a diverse range of professions 
within the field. They each bring a unique understanding of the issue because they work with 
women experiencing an opioid exposed pregnancy at different points of her pregnancy and often 
stages of treatment. Further, the sample represents experiences from regions across the state, 
including the east, the west, the piedmont, and the triangle. This strengthens the study because 
these regions vary greatly regarding their access to services. Some regions are more rural and 
lacking access to services, while others are suburban and urban and better connected to health 
and treatment services. 
 What emerged from the data is a consensus that North Carolina has enhanced its efforts 
to address opioids and pregnancy over recent years, however, the key concept that emerged from 
this study is the need for North Carolina to implement a change in practice regarding how the 
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state approaches treatment for opioid exposed pregnancies. Participants noted that increased 
knowledge, skills, and a shift in attitude would be required among a wide range of professionals 
serving and engaging this population. Participants stated that gaps in care were due largely to a 
lack of coordinated care, misinformation, and fear among providers. These gaps in care have 
resulted in substandard care at the minimum and egregious results at the worst. Participants 
highlighted specific changes that were needed, including increasing efforts to implement 
screening and increasing the number of physicians who prescribe Buprenorphine in general and 
specifically to pregnant women. Despite differences among those interviewed, including the 
needs and resources that are available by region, many of the same issues and trends emerged 
from all of the participants. Through the interviews the participants spontaneously arrived at 
many of the same issues. This suggests that this study has demonstrated a level of congruence 
regarding the leading challenges and suggested solutions as North Carolina addressed opioid 
exposed pregnancies.  
 As the numbers of opioid exposed pregnancies continue to rise in NC, it must be 
considered what the public health impact will be and how we can best address the medical and 
social needs of mothers and their children. Results from this research suggest that North Carolina 
program initiatives and policies aimed at addressing opioid exposed pregnancies should focus on 
a change in practice that would provide comprehensive training to increase knowledge, but also 
provide the skills needed to treat this population.  
 These recommendations are consistent with findings across the state, including the 2012 
survey designed to assess the knowledge and skills of professionals in North Carolina that work 
with this population and these finding align with what the NCPOEP workgroup have identified 
as key challenges in treating opioid exposed pregnancies. North Carolina can continue to work to 
implement changes through on-going training of professionals that increases both knowledge and 
skills, but also to focus on policies that reinforce and support best practices.  
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